1. Market Research
  2. > Pathology Industry
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

Cancer Industry, August 2017 Market Reports from Top Publishers

You might be interested in: Diagnostics, Molecular Diagnostic, Infectious Disease, Therapy, Hospital, Vaccine, Immunochemistry Test, Lung Cancer, Breast Cancer, Cancer Diagnostic, Pharmaceutical, Laboratory, Colorectal Cancer, Biopsy, Prostate Cancer, Injectable Delivery, Endoscope, Magnetic Resonance Imaging, Point Of Care Testing, Ambulatory Care.


 
1-10 of about 3200 reports for Cancer

Purchase Reports From Reputable Market Research Publishers

Global Radiopharmaceuticals Market 2017-2021

  • $ 3500
  • Industry report
  • August 2017
  • by Infiniti Research Limited

About Radiopharmaceuticals Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that ...

ASIA-PACIFIC CANCER BIOMARKER MARKET 2017-2025

  • $ 1238
  • Industry report
  • August 2017
  • by Inkwood Research

KEY FINDINGS The Asia-Pacific cancer biomarkers market is expected to speed up its growth with a CAGR of 15.73% for the years 2017-2025, generating a net worth of $8831 million. India is the fastest growing ...

EUROPE CANCER BIOMARKER MARKET FORECAST 2017-2025

  • $ 1238
  • Industry report
  • August 2017
  • by Inkwood Research

KEY FINDINGS The Europe cancer biomarker market is poised to grow at a CAGR of 13.46% for the years 2017-2025. The total income generated by the market is also predicted to increase to up to $8646 million ...

NORTH AMERICA CANCER BIOMARKER MARKET FORECAST 2017-2025

  • $ 1238
  • Industry report
  • August 2017
  • by Inkwood Research

KEY FINDINGS The United States is a primary contributor to the North American cancer biomarker market, which is all set to expand with a CAGR of 13.17% between the forecasted years of 2017-2025. The market ...

GLOBAL CANCER BIOMARKER MARKET FORECAST 2017-2025

  • $ 2475
  • Industry report
  • August 2017
  • by Inkwood Research

KEY FINDINGS The global cancer biomarker market is expected to grow at a CAGR of 14.07% between the years 2017- 2025, generating a net worth of $33026 million by the end of 2025. Some of the important ...

C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) – Pipeline Review, H2

  • $ 3500
  • Company report
  • August 2017
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Recepto ...

National Cancer Institute US - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2017
  • by GlobalData

Summary National Cancer Institute US (NCI), a subsidiary of National Institutes of Health is a provider of cancer research and training services. The institute coordinates National Cancer Program that ...

Global Cancer Gene Therapy Market 2017-2021

  • $ 3500
  • Industry report
  • August 2017
  • by Infiniti Research Limited

About Cancer Gene Therapy Cancer gene therapy is the treatment of cancer through gene therapy. The therapy uses genetically engineered vectors mostly viruses to deliver a gene into the individual’s body. ...

Familial Adenomatous Polyposis - Pipeline Review, H2 2017

  • $ 2000
  • Company report
  • August 2017
  • by Global Markets Direct

Familial Adenomatous Polyposis - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Familial Adenomatous Polyposis - Pipeline Review, ...

Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H2 2017

  • $ 2000
  • Company report
  • August 2017
  • by Global Markets Direct

Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Gorlin Syndrome (Basal Cell Nevus Syndrome) ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.